Fibrin Fibrinogen Degradation Products
"Fibrin Fibrinogen Degradation Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis.
| Descriptor ID |
D005338
|
| MeSH Number(s) |
D12.776.124.270.300 D12.776.811.300.290
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrin Fibrinogen Degradation Products".
Below are MeSH descriptors whose meaning is more specific than "Fibrin Fibrinogen Degradation Products".
This graph shows the total number of publications written about "Fibrin Fibrinogen Degradation Products" by people in this website by year, and whether "Fibrin Fibrinogen Degradation Products" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2004 | 0 | 4 | 4 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 3 | 3 |
| 2012 | 2 | 1 | 3 |
| 2013 | 0 | 2 | 2 |
| 2014 | 3 | 0 | 3 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 1 | 2 |
| 2019 | 3 | 1 | 4 |
| 2020 | 0 | 4 | 4 |
| 2021 | 1 | 2 | 3 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibrin Fibrinogen Degradation Products" by people in Profiles.
-
D-Dimer Elevation at Time of Admission is Associated with Need for Ventilator Support among Pediatric Patients with COVID-19 Infection. Clin Lab. 2023 Oct 01; 69(10).
-
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 07 20; 326(3):230-239.
-
d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Med. 2021 05 01; 49(5):e500-e511.
-
D-dimer levels predict COVID-19 severity and mortality. Kardiol Pol. 2021 02 25; 79(2):217-218.
-
Factors associated with deep venous thrombosis in patients infected with coronavirus disease 2019: a meta-analysis. Blood Coagul Fibrinolysis. 2021 Jan 01; 32(1):23-28.
-
Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19. Medicina (Kaunas). 2020 Dec 03; 56(12).
-
COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital Outcomes. Arterioscler Thromb Vasc Biol. 2020 11; 40(11):2764-2775.
-
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study. Cancer Med. 2020 09; 9(17):6196-6204.
-
SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020 07; 51(7):2002-2011.
-
Evaluation of Cancer Patients With Suspected Pulmonary Embolism: Performance of the American College of Physicians Guideline. J Am Coll Radiol. 2020 Jan; 17(1 Pt A):22-30.